As of 2025-07-05, the Fair Value of Repligen Corp (RGEN) is -6.06 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 127.47 USD, the upside of Repligen Corp is -104.76%.
With the market price of 127.47 USD and our fair value calculation, Repligen Corp (RGEN) is not a good investment. Investing in RGEN stocks now will result in a potential loss of 104.76%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 59.90 | 128.30 | 186.00 | 35.60 | -25.51 | 76.86 |
| YoY growth | 179.91% | 114.19% | 44.97% | -80.86% | -171.68% | 17.31% |
| Market Cap (mil) | 7,161.26 |
| P/E | |
| Forward P/E |
| EPS | -0.35 |
| Avg earnings growth rate | 17.31% |
| TTM earnings | -19.68 |